Segment Evaluation and Major Growth Areas in the In Vivo Contract Research Organization Market

The in vivo contract research organization (CRO) market is set to experience significant expansion over the coming years, driven by advancements in drug development and growing demand for specialized research services. Understanding the market's projected growth, key players, emerging trends, and segment details provides a clear picture of the sector's dynamic future.

Projected Market Size and Growth of the In Vivo Contract Research Organization Market
The global in vivo contract research organization market is anticipated to reach a valuation of $7.77 billion by 2030, expanding at a compound annual growth rate (CAGR) of 8.1%. This upward trajectory is fueled by factors such as the increasing need for accelerated drug development timelines, wider implementation of sophisticated in vivo disease models, growth in oncology and rare disease research, and the rising integration of AI-enabled preclinical analytics. Additionally, heightened regulatory scrutiny focusing on safety data is further propelling market expansion. Key trends include a growing preference for outsourcing preclinical research, demand for specialized disease models, adoption of GLP-compliant toxicology studies, development of integrated preclinical service packages, and a stronger emphasis on improving data quality and reproducibility.

Download a free report of the in vivo contract research organization market report:
https://www.thebusinessresearchcompany.com/report/in-vivo-contract-research-organization-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Key Companies Shaping the In Vivo Contract Research Organization Market
The market features a diverse range of prominent companies, including Thermo Fisher Scientific Inc, Labcorp Drug Development Inc, Eurofins Scientific SE, WuXi AppTec, Charles River Laboratories International Inc, Evotec SE, GemPharmatech Co Ltd, BIOQUAL Inc, Crown Bioscience Inc, PsychoGenics Inc, Janvier Labs SAS, Taconic Bioscience Inc, Xentech SAS, Altogen Labs Inc, AniLocus Inc, Pharmaron Beijing Co Ltd, Southern Research Institute, SRI International, Envigo RMS LLC, Horizon Discovery Group plc, Inotiv Inc, and GenScript ProBio.

Strategic Acquisition Expanding Market Reach
In September 2024, PharmaLegacy Laboratories Co. Ltd., a China-based preclinical CRO specializing in pharmacology, finalized the acquisition of BTS Research for an undisclosed sum. This move aims to enhance PharmaLegacy's preclinical service offerings and establish a strategic laboratory footprint in North America, providing stronger support for global biopharmaceutical clients. BTS Research Inc. is known for delivering both in vitro and in vivo programs and is based in the United States.

View the full in vivo contract research organization market report:
https://www.thebusinessresearchcompany.com/report/in-vivo-contract-research-organization-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Emerging Trends and Collaborations in the Contract Research Organization Market
Industry leaders are increasingly forming strategic partnerships to solidify their market positions. Such alliances typically involve formal agreements between companies to combine their expertise and expand service portfolios. For example, in February 2023, HOYA Vision Care, an optical technology firm based in Thailand, partnered with Japan's NIDEK Co. Ltd. This collaboration allows HOYA to access a comprehensive range of cutting-edge optical instruments and products, enabling a full-service patient care approach-from eye examinations to consultations and delivery of premium spectacle lenses. NIDEK specializes in the design, manufacture, and distribution of ophthalmic and optometric equipment.

Detailed Segmentation of the In Vivo Contract Research Organization Market
The report categorizes the in vivo contract research organization market into several key segments:
1) By Type: Rodent-Based Models and Non-Rodent-Based Models
2) By Type of Service: Translational and IND-Enabling In Vivo Studies, Preclinical Services, Post-Approval Nonclinical Safety and Mechanistic Studies
3) By Good Laboratory Practice (GLP) Status: GLP-Compliant Toxicology and Non-GLP Services
4) By Application Area: Oncology, Cardiovascular Diseases, Infectious Diseases, Neurological Disorders, and Other Applications
5) By End User: Pharmaceutical Companies, Biotechnology Firms, CROs, Academic and Research Institutions, and Government/Regulatory Agencies

Further Breakdown of Key Subsegments
Within rodent-based models, subcategories include mice models, rat models, genetically engineered rodents, immunodeficient rodents, and humanized rodents. For non-rodent models, the segments cover canine models, non-human primate models, swine models, rabbit models, and zebrafish models, illustrating the broad range of animal models used to support diverse preclinical research needs.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.